Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical effectiveness of olanzapine, quetiapine and aripiprazole vs low-dose conventional antipsychotics in schizophrenia
DRKS00000304Phase 4Completed
- Sponsor
- Universität Bremen
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olanzapine, quetiapine, aripiprazole, haloperidol and flupentixol in schizophrenia (2 arms), sponsored by Universität Bremen. Started Dec 2009; status: completed.
02
Drugs
olanzapinequetiapinearipiprazolehaloperidolflupentixol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00000304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000304.